Age-related macular degeneration causes irreversible vision loss in over twenty million patients in the US alone. Existing treatments slow progression, but have no impact on the upstream drivers of disease.
Ocutheia is pioneering a new approach to preserving vision by targeting metabolic dysfunction in photoreceptors. Our approach has broad therapeutic potential in the retina and even beyond the eye.
Company Details
- Employees
- 4
- Founded
- 2022
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://ocutheia.com
- Keywords
- Vitória.
Ocutheia, Inc. Questions
Ocutheia, Inc.'s website is http://ocutheia.com
Ocutheia, Inc.'s LinkedIn profile is https://www.linkedin.com/company/ocutheia-inc
Ocutheia, Inc. has
4 employees.
View email and phone details for 4
employees at Ocutheia, Inc..
Ocutheia, Inc.'s industry is
Biotechnology Research
Ocutheia, Inc.'s top competitors are
Telo Therapeutics, Inc.,
Ocular Oftalmologia Vitória,
Junevity,
Eyecare Specialists,
Adtech Juice,
Curio Eyecare,
Arclight Therapeutics,
Mbc Biolabs,
Gulf Coast Eye Center,
Deciduous Therapeutics.
Ocutheia, Inc.'s categories are Biotechnology Research
Ocutheia, Inc.'s founding year is 2022
